REQUEST A DEMO
Total
USD $0.00
Search more companies

Centrum Specjalistyczne Biomed Borowscy sp. j. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Centrum Specjalistyczne Biomed Borowscy sp. j. Profile Updated: May 25, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Centrum Specjalistyczne Biomed Borowscy sp. j. is an enterprise based in Poland. Its main office is in Boleslawiec. The company operates in the Ambulatory Health Care Services sector. The company was established on June 25, 2014. There was a net sales revenue increase of 34.24% reported in Centrum Specjalistyczne Biomed Borowscy sp. j.’s latest financial highlights for 2022. Over the same period, its total assets decreased by 10.95%. The net profit margin of Centrum Specjalistyczne Biomed Borowscy sp. j. increased by 1.9% in 2022.

Headquarters
Ul. Piaskowa 15
Boleslawiec; Dolnoslaskie; Postal Code: 59-700

Contact Details: Purchase the Centrum Specjalistyczne Biomed Borowscy sp. j. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centrum Specjalistyczne Biomed Borowscy sp. j. report to view the information.
Incorporation Date:
June 25, 2014
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Centrum Specjalistyczne Biomed Borowscy sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
34.24%
Total operating revenue
27.75%
Operating profit (EBIT)
47.89%
EBITDA
40.09%
Net Profit (Loss) for the Period
47.89%
Total assets
-10.95%
Total equity
-20.61%
Operating Profit Margin (ROS)
1.9%
Net Profit Margin
1.9%
Return on Equity (ROE)
42.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?